Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T-cells expressing anti-LIV1 chimeric antigen receptor

T-cells expressing anti-LIV1 chimeric antigen receptor

US Patent 12304968 · Granted May 20, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Gene-edited natural killer cells2025
Genetically engineered T cells having improved persistence in culture2025
Methods and compositions for treating cancer2025
Activatable anti-VEGF scFv2025
Anti-PTK7 immune cell cancer therapy2024
Anti-PTK7 immune cell cancer therapy2024
Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related cond2024
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK2024
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK2024